Company intelligence / Profile preview

Epigeneres Biotech

Mumbai, Maharashtra, India

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Epigeneres Biotech is a Mumbai-based biotechnology company specializing in early cancer detection and regenerative medicine. The company is best known for its proprietary HrC (High-resolution Cancer) technology, a non-invasive blood test capable of detecting various types of cancer at very early stages, including Stage 0. Their research focuses on the role of Very Small Embryonic-Like stem cells (VSELs) and epigenetic markers in disease progression. Epigeneres operates in collaboration with Singapore-based Tzar Labs to commercialize diagnostic solutions globally. Beyond diagnostics, the company explores stem cell-based therapies for regenerative applications.

Therapeutic areas: Oncology
Modalities: BiologicCell therapy
Industry: Molecular Diagnostics

Partnerships

Tzar LabsApollo Hospitals

Beyond the preview

Go deeper on Epigeneres Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epigeneres Biotech.

Explore the full profile